Wein S, Ukropec J, Gasperíková D, Klimes I, Seböková E
Diabetes and Nutrition Research Laboratory, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Exp Clin Endocrinol Diabetes. 2007 Apr;115(4):244-51. doi: 10.1055/s-2007-956166.
Central action of leptin on food intake and energy expenditure is integrated with leptin's peripheral action modulating the fatty acid and glucose metabolism and preventing the accumulation of lipids in nonadipose tissues. However, exact mechanism(s) of the leptin's action in the peripheral tissues has not yet been fully elucidated. Therefore, we investigated the effect of a single intravenous injection of leptin on palmitoyl-CoA and palmitoyl-carnitine oxidation rate in liver and skeletal muscle followed by measurements of the carnitine-palmitoyl transferase 1 (CPT1) activity and activities of ss-oxidation enzymes in mitochondria (acyl-CoA dehydrogenase) and in peroxisomes (acyl-CoA oxidase) of rats. Animals were euthanized and tissues and serum harvested 15 min, 1 hour, 3 hours and 6 hours after leptin administration. Intravenous leptin injection increased mitochondrial palmitoyl-CoA oxidation rate in both liver (95%; P<0.025) and skeletal muscle (2.7-fold; P<0.05). This was paralleled by lowering hepatic (-156%; P<0.001) and skeletal muscle (-191%; P<0.001) triglyceride content. Leptin-induced elevation of palmitoyl-CoA oxidation rate in liver was paralleled by increased CPT1 activity (52%; P<0.05) and ss-oxidation capacity (52%; P<0.05). Lack of the leptin's effect on the CPT1-activity in muscle (20%; p=0.09) suggests the existence of an alternative pathway for increasing the palmitoyl-CoA-oxidation rate bypassing the CPT1 regulatory step. Interestingly, leptin stimulated the overall ss-oxidation capacity in muscle by 69% (P=0.027). This may indicate to an involvement of mitochondrial acyl-CoA dehydrogenases as well as of peroxisomal fat catabolism. Taken together, we showed that leptin acutely increases palmitoyl-CoA oxidation rate in liver and in skeletal muscle, which was associated with tissue specific effect on the CPT1 activity as well as on the downstream enzymes of fatty acid oxidation pathways in rat mitochondria and peroxisomes. Tangible evidence for the leptin-induced increase of fatty acid catabolism was provided by a lowered skeletal muscle and hepatic lipid deposition.
瘦素对食物摄入和能量消耗的中枢作用与瘦素的外周作用相结合,后者可调节脂肪酸和葡萄糖代谢,并防止脂质在非脂肪组织中积累。然而,瘦素在外周组织中的具体作用机制尚未完全阐明。因此,我们研究了单次静脉注射瘦素对大鼠肝脏和骨骼肌中棕榈酰辅酶A和棕榈酰肉碱氧化速率的影响,随后测量了肉碱 - 棕榈酰转移酶1(CPT1)的活性以及线粒体(酰基辅酶A脱氢酶)和过氧化物酶体(酰基辅酶A氧化酶)中β-氧化酶的活性。在给予瘦素后15分钟、1小时、3小时和6小时对动物实施安乐死并采集组织和血清。静脉注射瘦素可使肝脏(95%;P<0.025)和骨骼肌(2.7倍;P<0.05)中的线粒体棕榈酰辅酶A氧化速率增加。同时,肝脏(-156%;P<0.001)和骨骼肌(-191%;P<0.001)中的甘油三酯含量降低。瘦素诱导肝脏中棕榈酰辅酶A氧化速率升高的同时,CPT1活性(52%;P<0.05)和β-氧化能力(52%;P<0.05)也增加。瘦素对肌肉中CPT1活性无影响(20%;p = 0.09),这表明存在一条绕过CPT1调节步骤来增加棕榈酰辅酶A氧化速率的替代途径。有趣的是,瘦素使肌肉中的整体β-氧化能力提高了69%(P = 0.027)。这可能表明线粒体酰基辅酶A脱氢酶以及过氧化物酶体脂肪分解参与其中。综上所述,我们表明瘦素可急性增加肝脏和骨骼肌中棕榈酰辅酶A的氧化速率,这与对CPT1活性以及大鼠线粒体和过氧化物酶体中脂肪酸氧化途径下游酶的组织特异性作用有关。骨骼肌和肝脏脂质沉积减少为瘦素诱导脂肪酸分解增加提供了确凿证据。